Home/Compounds/Pharmaceutical Intermediate/N-(2-Chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine
C14H14ClN5
287.75 g/mol
Pharmaceutical IntermediateDanger
N-(2-chloro-4-pyrimidinyl)-N,2,3-trimethyl-2H-Indazol-6-amine
CAS444731-75-3
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
This compound is a chemical compound used as a pharmaceutical intermediate. It is primarily utilized in the manufacturing process of pazopanib, a targeted therapy agent.
Pharmaceutical intermediate for pazopanib manufacturingLaboratory research compound in oncology drug development
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 444731-75-3
Related Compounds
ReferenceSame Category
2-Amino-4-chlorobenzotrifluoride
CAS445-14-7
pharmaceutical intermediate
ReferenceSame Category
2'-Fluoroacetophenone
CAS445-27-2
pharmaceutical intermediate
ReferenceSame Category
2-Fluorobenzoic acid
CAS445-29-4
pharmaceutical intermediate
ReferenceSame Category
N-(1-((1R,3R,4R,7S)-1-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-7-hydroxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide
CAS445012-77-1
pharmaceutical intermediate
Referencesame scaffold
N-(2-Chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine
CAS444731-74-2
pharmaceutical intermediate
Safety Reference
Danger
H301Toxic if swallowed
H302Harmful if swallowed
H319Causes serious eye irritation
H341Suspected of causing genetic defects
H361Suspected of damaging fertility or the unborn child
H362May cause harm to breast-fed children
H412Harmful to aquatic life with long lasting effects
Identifiers
IUPAC Name
N-(2-chloropyrimidin-4-yl)-N,2,3-trimethylindazol-6-amine
InChIKey
DVGMRZQSSNNTFY-UHFFFAOYSA-N
SMILES
CC1=C2C=CC(=CC2=NN1C)N(C)C3=NC(=NC=C3)Cl
Synonyms (8)
- Pazopanib related